These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 28228395)

  • 1. Antibody Responses to Zika Virus Infections in Environments of Flavivirus Endemicity.
    Keasey SL; Pugh CL; Jensen SMR; Smith JL; Hontz RD; Durbin AP; Dudley DM; O'Connor DH; Ulrich RG
    Clin Vaccine Immunol; 2017 Apr; 24(4):. PubMed ID: 28228395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Anti-Premembrane Antibody as a Serocomplex-Specific Marker To Discriminate Zika, Dengue, and West Nile Virus Infections.
    Hsieh SC; Tsai WY; Tsai JJ; Stone M; Simmons G; Busch MP; Lanteri M; Stramer SL; Balmaseda A; Harris E; Wang WK
    J Virol; 2021 Sep; 95(19):e0061921. PubMed ID: 34232731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T Cell Responses Induced by Attenuated Flavivirus Vaccination Are Specific and Show Limited Cross-Reactivity with Other Flavivirus Species.
    Grifoni A; Voic H; Dhanda SK; Kidd CK; Brien JD; Buus S; Stryhn A; Durbin AP; Whitehead S; Diehl SA; De Silva AD; Balmaseda A; Harris E; Weiskopf D; Sette A
    J Virol; 2020 May; 94(10):. PubMed ID: 32132233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.
    Lai H; Paul AM; Sun H; He J; Yang M; Bai F; Chen Q
    Vaccine; 2018 Mar; 36(14):1846-1852. PubMed ID: 29490880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-Reactive T Cell Immunity to Dengue and Zika Viruses: New Insights Into Vaccine Development.
    Elong Ngono A; Shresta S
    Front Immunol; 2019; 10():1316. PubMed ID: 31244855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Tale of Two Viruses: Does Heterologous Flavivirus Immunity Enhance Zika Disease?
    Sariol CA; Nogueira ML; Vasilakis N
    Trends Microbiol; 2018 Mar; 26(3):186-190. PubMed ID: 29122447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Previous dengue or Zika virus exposure can drive to infection enhancement or neutralisation of other flaviviruses.
    Oliveira RA; de Oliveira-Filho EF; Fernandes AI; Brito CA; Marques ET; Tenório MC; Gil LH
    Mem Inst Oswaldo Cruz; 2019; 114():e190098. PubMed ID: 31411310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Envelope Protein Antigens To Serologically Differentiate Zika Virus Infection from Dengue Virus Infection.
    Premkumar L; Collins M; Graham S; Liou GA; Lopez CA; Jadi R; Balmaseda A; Brackbill JA; Dietze R; Camacho E; De Silva AD; Giuberti C; Dos Reis HL; Singh T; Heimsath H; Weiskopf D; Sette A; Osorio JE; Permar SR; Miley MJ; Lazear HM; Harris E; de Silva AM
    J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29263206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme-linked immunosorbent assays using virus-like particles containing mutations of conserved residues on envelope protein can distinguish three flavivirus infections.
    Tsai WY; Driesse K; Tsai JJ; Hsieh SC; Sznajder Granat R; Jenkins O; Chang GJ; Wang WK
    Emerg Microbes Infect; 2020 Dec; 9(1):1722-1732. PubMed ID: 32684139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus.
    Swanstrom JA; Plante JA; Plante KS; Young EF; McGowan E; Gallichotte EN; Widman DG; Heise MT; de Silva AM; Baric RS
    mBio; 2016 Jul; 7(4):. PubMed ID: 27435464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of anti-premembrane antibody as a specific marker of four flavivirus serocomplexes and its application to serosurveillance in endemic regions.
    Chen GH; Dai YC; Hsieh SC; Tsai JJ; Sy AK; Jiz M; Pedroso C; Brites C; Netto EM; Kanki PJ; Saunders DRD; Vanlandingham DL; Higgs S; Huang YS; Wang WK
    medRxiv; 2023 Sep; ():. PubMed ID: 37808865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replication in the presence of dengue convalescent serum impacts Zika virus neutralization sensitivity and fitness.
    Marano JM; Weger-Lucarelli J
    Front Cell Infect Microbiol; 2023; 13():1130749. PubMed ID: 36968111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ELISPOT-Based "Multi-Color FluoroSpot" to Study Type-Specific and Cross-Reactive Responses in Memory B Cells after Dengue and Zika Virus Infections.
    Andrade P; Coloma J; Harris E
    Methods Mol Biol; 2018; 1808():151-163. PubMed ID: 29956181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody cross-reactivity and evidence of susceptibility to emerging Flaviviruses in the dengue-endemic Brazilian Amazon.
    Salgado BB; Maués FCJ; Jordão M; Pereira RL; Toledo-Teixeira DA; Parise PL; Granja F; Souza HFS; Yamamoto MM; Chiang JO; Martins LC; Boscardin SB; Lalwani JDB; Vasconcelos PFC; Proença-Modena JL; Lalwani P
    Int J Infect Dis; 2023 Apr; 129():142-151. PubMed ID: 36736575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus.
    Priyamvada L; Quicke KM; Hudson WH; Onlamoon N; Sewatanon J; Edupuganti S; Pattanapanyasat K; Chokephaibulkit K; Mulligan MJ; Wilson PC; Ahmed R; Suthar MS; Wrammert J
    Proc Natl Acad Sci U S A; 2016 Jul; 113(28):7852-7. PubMed ID: 27354515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal Analysis of Antibody Cross-neutralization Following Zika Virus and Dengue Virus Infection in Asia and the Americas.
    Montoya M; Collins M; Dejnirattisai W; Katzelnick LC; Puerta-Guardo H; Jadi R; Schildhauer S; Supasa P; Vasanawathana S; Malasit P; Mongkolsapaya J; de Silva AD; Tissera H; Balmaseda A; Screaton G; de Silva AM; Harris E
    J Infect Dis; 2018 Jul; 218(4):536-545. PubMed ID: 29618091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of Flavivirus Neutralizing Antibodies in Thailand by High-Throughput Neutralization Assay: Endemic Circulation of Zika Virus before 2012.
    Yamanaka A; Matsuda M; Okabayashi T; Pitaksajjakul P; Ramasoota P; Saito K; Fukasawa M; Hanada K; Matsuura T; Muramatsu M; Shioda T; Suzuki R
    mSphere; 2021 Aug; 6(4):e0033921. PubMed ID: 34259560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A high-throughput multiplex assay to characterize flavivirus-specific immunoglobulins.
    Merbah M; Wollen-Roberts S; Shubin Z; Li Y; Bai H; Dussupt V; Mendez-Rivera L; Slike B; Krebs SJ; Modjarrad K; Michael NL; Rolland M
    J Immunol Methods; 2020 Dec; 487():112874. PubMed ID: 33022219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Infections of Zika, Dengue, and Yellow Fever Viruses in Human Cytotrophoblast-Derived Cells Suggest a Gating Role for the Cytotrophoblast in Zika Virus Placental Invasion.
    Viettri M; Caraballo G; Sanchez ME; Espejel-Nuñez A; Betanzos A; Ortiz-Navarrete V; Estrada-Gutierrez G; Nava P; Ludert JE
    Microbiol Spectr; 2023 Jun; 11(3):e0063023. PubMed ID: 37227282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiplex detection of antibodies to Chikungunya, O'nyong-nyong, Zika, Dengue, West Nile and Usutu viruses in diverse non-human primate species from Cameroon and the Democratic Republic of Congo.
    Raulino R; Thaurignac G; Butel C; Villabona-Arenas CJ; Foe T; Loul S; Ndimbo-Kumugo SP; Mbala-Kingebeni P; Makiala-Mandanda S; Ahuka-Mundeke S; Kerkhof K; Delaporte E; Ariën KK; Foulongne V; Mpoudi Ngole E; Peeters M; Ayouba A
    PLoS Negl Trop Dis; 2021 Jan; 15(1):e0009028. PubMed ID: 33476338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.